Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Mouse (Murine) Antikörper:
anti-Rat (Rattus) Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal SEMA3A Primary Antibody für IHC (p), ELISA - ABIN548435
Luo, Raible, Raper: Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. in Cell 1993
Show all 6 Pubmed References
Human Monoclonal SEMA3A Primary Antibody für CyTOF, FACS - ABIN4899982
Chakraborty, Kumar, Mishra, Patil, Kundu: Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. in PLoS ONE 2012
Show all 4 Pubmed References
Human Polyclonal SEMA3A Primary Antibody für CyTOF, FACS - ABIN4899983
Tatsumi, Sankoda, Anderson, Sato, Mizunoya, Shimizu, Suzuki, Yamada, Rhoads, Ikeuchi, Allen: Possible implication of satellite cells in regenerative motoneuritogenesis: HGF upregulates neural chemorepellent Sema3A during myogenic differentiation. in American journal of physiology. Cell physiology 2009
Human Polyclonal SEMA3A Primary Antibody für ELISA, WB - ABIN5519059
Zhou, Wu, Fu, Lv, Zhang: Significance of semaphorin-3A and MMP-14 protein expression in non-small cell lung cancer. in Oncology letters 2014
Human Polyclonal SEMA3A Primary Antibody für ELISA, WB - ABIN548415
Kolodkin, Matthes, Goodman: The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. in Cell 1994
Show all 3 Pubmed References
Human Polyclonal SEMA3A Primary Antibody für ELISA, WB - ABIN548433
Pasterkamp, Verhaagen: Emerging roles for semaphorins in neural regeneration. in Brain research. Brain research reviews 2001
Show all 3 Pubmed References
Human Polyclonal SEMA3A Primary Antibody für IF (p), IHC (p) - ABIN737961
Zhang, Ishikawa, Inagawa, Ikemoto, Guo, Sunagawa, Hisamitsu: Influence of Mechanical Force on Bone Matrix Proteins in Ovariectomised Mice and Osteoblast-like MC3T3-E1 Cells. in In vivo (Athens, Greece) 2017
Semaphorin 3A is overexpressed in urothelial cancer patients, as evidenced both in its presence in urine and in bladder tissue.
the inhibitory effect of Sema3C on microcapillary formation by human umbilical vein endothelial cells could be abrogated upon mutation at the Sema3C basic domain within putative furin cleavage site 742RNRR745, indicating that this site was essential for the Sema3 biological activity.
Results provide evidence that SEMA3A is highly expressed in glioblastoma (GBM) compared to non-neoplastic brain tissues and SEMA3A signaling axis promotes GBM growth and invasion.
these findings shows that miR-362 promotes lung cancer metastasis through downregulation of Sema3A
These findings indicate a regulatory mechanism and a proapoptotic function of aberrant Sema3A signaling in Osteoarthritis (OA) chondrocytes, and suggest that targeting Sema3A signaling might interfere OA pathogenesis.
increased concentrations of urinary SEMA-3A and urinary Netrin-1 are found in urine from children with severe hydronephrosis and that their concentrations are related to the degree of obstruction.
Advanced peri-implantitis lesions showed higher levels of gene expression for Sem3A and Sem4D and lower levels of Sem4A in comparison to tissues obtained from a healthy dental implant.
clinical samples from apical periodontitis patients were obtained to analyse the expression of Sema3A/Nrp1. These results indicated that the bone destruction level expanded from days 7 to 35
study demonstrates that Sema3E/plexinD1 inhibits proliferation and migration of vascular smooth muscle cells via inactivation of Rap1-AKT signalling pathways
Results showed a preferential association of NRP1 with SEMA3A, suggesting that SEMA3A can partially reverse the effects caused by the VEGFA preventing its binding with the NRP1 receptor.
Our observation of a second case supports the notion that bi-allelic mutations in SEMA3A cause an autosomal recessive type of syndromic short stature.
the upregulation of SEMA3A in hepatocellular carcinoma (HCC)cells promoted tumor growth and progression in an HCC mouse model. These results indicate that SEMA3A enhances CapG, galectin-3, enolase 2 and EpCAM expression to promote HCC progression and is a potential therapeutic target for HCC.
Sema3A as a novel regulator of airway smooth cell proliferation by suppressing Rac1, GSK-3beta and STAT3 signaling mediated by Nrp1.
provide an easy and reproducible method to analyze growth cone sensitivity to the prototypic guidance molecule family class 3 semaphorin
Measuring electrical impedance allows real-time monitoring of changes in endothelial cell morphology and adhesion induced by SEMA3E via plexin D1
describe a method where in vitro cultures of growth cones are incubated with these ligands in the presence or absence of Sema3A, followed by stripping of remaining ligand on cell-surface and analysis by immunofluorescence techniques
Semaphorin 3A increased tumor-infiltrating macrophages (TAM) infiltration and promoted hepatocellular carcinoma (HCC) progression. Semaphorin 3A expression alone, or combined with the number of TAMs, is a new prognostic factor and potential target for the treatment of HCC.
Significant genetic risk for Hirschsprung disease (HSCR) was imparted by rs2435357 and rs2506030 at RET and by rs12707682 at SEMA3 in a Chinese population. No evidence was found of a genetic association between HSCR and either of the NRG1 SNPs rs7835688 and rs16879552, at either allele or genotype level.
rs139438618 at the semaphorin 3A locus was significantly associated with Alcohol Dependence and Major Depression comorbidity in African Americans. There was no significant association identified in European American participants.
Serum level of Sema3A taken from diagnosed celiac without gluten-free diet was higher significantly than healthy controls.
Sema3a1 is a guidance factor for neural growth cones and has a role in the development of the vascular system
Sema3a1 plays an essential role in guiding the caudal primary (CaP) motor axon that pioneers the initial region of the motor pathway.
This gene is a member of the semaphorin family and encodes a protein with an Ig-like C2-type (immunoglobulin-like) domain, a PSI domain and a Sema domain. This secreted protein can function as either a chemorepulsive agent, inhibiting axonal outgrowth, or as a chemoattractive agent, stimulating the growth of apical dendrites. In both cases, the protein is vital for normal neuronal pattern development. Increased expression of this protein is associated with schizophrenia and is seen in a variety of human tumor cell lines. Also, aberrant release of this protein is associated with the progression of Alzheimer's disease.
, semaphorin D
, semaphorin III
, semaphorin L
, sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
, sema D
, sema III
, Semaphorin 3a
, sema domain, immunoglobulin domain (Ig), short basic domain, sec
, semaphorin 3A
, sema Z1A
, semaphorin 1a